Next Safety, Inc.'s responds to the no-smoking ban in the United Kingdom with its revolutionary pulmonary drug delivery device. The handheld device delivers nicotine more effectively than a cigarette, without the smoke. It has enormous potential in the United Kingdom, and other areas of the world, where no-smoking bans have gone into effect.
WEST JEFFERSON, N.C. (BusinessWire EON) July 3, 2007 --
Next Safety, Inc.’s responds to the no-smoking
ban in the United Kingdom with its revolutionary pulmonary drug delivery
device. The handheld device delivers nicotine more effectively than a
cigarette, without the smoke. It has enormous potential in the United
Kingdom, and other areas of the world, where no-smoking bans have gone
into effect.
Roughly the size of a pack of cigarettes, the device will be used in
much the same way as current inhalers. The nicotine is supplied in
replaceable cartridges; the cartridges are monitored by electronically
stored information to ensure safe dosing. Battery powered circuitry
monitors the system to create and deliver nicotine to the lungs at the
optimal point during inhalation. The nicotine is delivered through a
mouthpiece connected to the system by a flexible hose. THE RESULT: Using
this breakthrough technology, Next Safety has delivered nicotine with
such high efficiency and efficacy that an inhaled dose equal to less
than 30 percent of that inhaled from the average cigarette yields
psychoactive results that last 12 to 18 hours in the average person.
Receptors in the brain receive nicotine rapidly without the
inhalation of the more than 300 combustion byproducts contained in
cigarette smoke. The device delivers extremely high arterial levels
of nicotine – with effects felt less than ten
seconds after inhalation – and provides higher
psychoactive effects than cigarettes or any other tobacco product on the
market.
Persons using the hand held device still get the nicotine “hit”
that they crave, but won’t be breaking any new “no-smoking”
laws. The company looks forward to working with the National Health
Service organisations to support their important leadership in removing
the carcinogens from public spaces.
“Next Safety, Inc. offers the only solution
to the no-smoking ban,” said C. Eric Hunter,
CEO and founder of Next Safety, Inc. “This
type of technology has never been seen before. It is a tremendous
breakthrough that will save millions of lives as well as allow public
and private establishments to operate without losing the revenue of a
smoking public.”
Initially, the unit will be provided to unregulated global markets with
availability in other areas following regulatory compliance. Next
Safety, Inc. anticipates production volumes will reach more than one
million units monthly in the first quarter of 2008. Primary
manufacturing capacity will be provided through contract-manufacturing
firms and a significant expansion of Next Safety’s
West Jefferson, North Carolina, USA facility.
In addition to nicotine, Next Safety will soon launch drug delivery
tests utilizing its pulmonary drug delivery method and devices that will
include antibiotics (tobramycin), anti-emetics (promethazine),
bronchodilators (albuterol), and narcotics (morphine).
About Next Safety, Inc.
Next Safety is located in North Carolina, an area already known for
leadership in technology and medicine. The company has leveraged this
expertise to develop the worlds most advanced respirator technology and
to advance the field of pulmonary medicine. Next Safety's bPure8000™
line of respirators provide higher protection against airborne viruses
and fine particulate air pollution than any other respirator available
globally. Next Safety now brings the same innovative approach to the
science of pulmonary drug delivery and nicotine replacement.
For more information about Next Safety, Inc. visit www.NextSafety.com
MULTIMEDIA GALLERY http://www.businesswire.com/cgi-bin/mmg.cgi?eid=5440405
Trackback URL: http://www.prweb.com/pingpr.php/WmV0YS1FbXB0LVNxdWEtUGlnZy1UaGlyLVplcm8=
|
